Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1Phase 1 1

Status

Completed 2Withdrawn 1Terminated 1No longer available 1

Sponsor Class

INDUSTRY 5OTHER 2

Study Type

Interventional 4Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 3Sarcoma 1Plasma cell 1Lymphoid 1

Conditions

Klatskin Tumor 2Cholangiocarcinoma 2Sarcoma, Kaposi 1Pancreatic Neoplasms 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Lymphoma 1Epstein-Barr Virus Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 313atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide × Clear all
NCT03377179 2025-07-23

A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma

RedHill Biopharma Limited

Phase 2 Completed
65 enrolled
Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

NCT03414489 2025-03-18

Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)

RedHill Biopharma Limited

No longer available
Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

NCT02757326 2021-06-18

ABC-103

RedHill Biopharma Limited

Phase 1/2 Terminated
13 enrolled 12 charts
Plasma cell

Multiple Myeloma

NCT01488513 2020-01-07

ABC-101

RedHill Biopharma Limited

Phase 1 Completed
22 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02229981 2017-12-07

ABC-102

RedHill Biopharma Limited

Phase 1/2 Withdrawn
LymphoidSarcoma

Acquired Immunodeficiency Syndrome, Lymphoma, Lymphoma, Non-Hodgkin, Sarcoma, Kaposi, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡